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Abstract
Background: Real-time quantitative PCR can be a very powerful and accurate technique to
examine gene transcription patterns in different biological conditions. One of the critical steps in
comparing transcription profiles is accurate normalisation. In most of the studies published on real-
time PCR in horses, normalisation occurred against only one reference gene, usually GAPDH or
ACTB, without validation of its expression stability. This might result in unreliable conclusions,
because it has been demonstrated that the expression levels of so called "housekeeping genes" may
vary considerably in different tissues, cell types or disease stages, particularly in clinical samples
associated with malignant disease. The goal of this study was to establish a reliable set of reference
genes for studies concerning normal equine skin and equine sarcoids, which are the most common
skin tumour in horses.
Results: In the present study the gene transcription levels of 6 commonly used reference genes
(ACTB, B2M, HPRT1, UBB, TUBA1 and RPL32) were determined in normal equine skin and in equine
sarcoids. After applying the geNorm applet to this set of genes, TUBA1, ACTB and UBB were found
to be most stable in normal skin and B2M, ACTB and UBB in equine sarcoids.
Conclusion: Based on these results, TUBA1, ACTB and UBB, respectively B2M, ACTB and UBB can
be proposed as reference gene panels for accurate normalisation of quantitative data for normal
equine skin, respectively equine sarcoids. When normal skin and equine sarcoids are compared,
the use of the geometric mean of UBB, ACTB and B2M can be recommended as a reliable and
accurate normalisation factor.
Background
Gene expression analysis has become increasingly impor-
tant in biological research where e.g. gene expression pro-
files from tissues associated with diseases and disorders
have to be compared with each other and with those from
normal tissues. One of the most powerful tools in this
area is real-time quantitative reverse transcription PCR
(qRT-PCR). To account for differences in starting material,
RNA preparation, RNA quality and cDNA synthesis, ade-
quate normalisation is frequently performed by compar-
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ing expression profiles of the genes of interest with those
of constitutively expressed genes (= reference genes).
Housekeeping genes are most widely used as reference
genes, based on the assumption that they are constitu-
tively expressed in most tissues and under certain circum-
stances, and that they are more or less resistant to cell cycle
fluctuations [1,2]. However, it has been demonstrated
that the expression levels of these genes may vary consid-
erably in different tissues, different cell types and different
disease stages, particularly in clinical samples associated
with malignant disease [3,4]. Housekeeping genes are not
only involved in the basal cell metabolism, but appear to
participate in other functions too, and therefore are prone
to regulation [5-7]. Especially in tumours, the metabolism
is generally elevated because of permanent proliferation
and expansion. Moreover, some housekeeping genes may
have a specific function essential for the tumour metabo-
lism and therefore be up or down regulated [8]. Because
of these findings, Vandesompele et al [9] proposed to
identify a set of stable housekeeping genes in the tissue of
interest and use them as internal reference genes for accu-
rate normalisation.
Up till now, only a few gene expression studies using real-
time qRT-PCR have been performed in horses. GAPDH or
ACTB were commonly used as a single non-validated ref-
erence gene [10-15], since at that time not much informa-
tion was available concerning this issue. Recently,
Waguespack et al [16] compared 4 housekeeping genes
(ACTB, B2M, GAPDH and TBP) in the lamellae of the
hoof in horses.
In this study, 6 commonly used reference genes in both
human and animal studies were investigated, both in nor-
mal skin and in equine sarcoids of horses. Equine sarcoids
are fibroblastic skin tumours and are the most common
tumours in horses. The disease not only induces esthetical
defects, but also diminishes the economical value of
affected horses [17]. Moreover affected horses show a
genetic predisposition for the development of equine sar-
coids, through which the breeding value of an animal
with sarcoids sharply declines [18-20]. The bovine papil-
lomavirus (BPV) plays an important role in the aetiology
of equine sarcoids [21-23]. Several clinical types exist,
ranging from small, stable patches to large, aggressive and
fast growing tumours [24]. To be able to examine the gene
expression profile of BPV in these different clinical types
and to compare equine sarcoids with normal skin asymp-
tomatically infected with BPV, a well suited internal con-
trol should first of all be established.
Results and discussion
Transcription profiling of the candidate genes
cDNA was synthesised from DNA-free RNA (checked with
minus RT control) isolated from 8 normal equine skin
and 8 equine sarcoid samples. A real-time PCR assay,
based on SYBR® Green detection, was designed for the
transcription profiling of six frequently used reference
genes (ACTB, B2M, HPRT1, UBB, TUBA1 and RPL32 )in
these cDNA samples. During optimisation of the proto-
col, real-time PCR products were visualised by gelelectro-
phoresis and sequenced for verification. For every assay, a
single amplicon with the expected size was generated
without primer dimer formation. Indeed, the formation
of primer dimers and unspecific amplification, which can
falsely increase the gene expression levels, is a major point
of attention, particularly when using intercalating dyes
such as SYBR® Green.
Amplicon sequences of ACTB, B2M, HPRT1, and TUBA1
were 100% identical with the described sequences on
which primer design was based. The sequencing of UBB
revealed 1 gap and 3 SNPs compared to the original
sequence (98% identity). The gap is probably due to
sequencing errors; the SNPs did not result in an amino
acid variation. When translated to amino acid sequence,
the RPL32 sequence was 100% identical to publicly acces-
sible horse ESTs and human RPL32 amino acid sequences.
After optimisation, gene-specific amplification was con-
firmed by a single peak in melt-curve analysis. For each
assay, a standard curve was generated by using 10-fold
serial dilutions of pooled cDNA, generated of both nor-
mal skin and equine sarcoid tissue, characterised by a lin-
ear correlation coefficient (R2) varying from 0.991 to
0.998 and a PCR efficiency between 88.1 and 104.6%.
These findings showed that these assays are suitable for
quantitative purposes.
In order to select a reliable set of reference genes, each
assay was performed in duplicate and included the appro-
priate control samples. To compare the transcription level
of the selected genes across the different samples, the Ct
values, ranging from 16.4 to 31.4 were converted into raw
data based on the PCR efficiency, gathered by standard
curve analyses.
GeNorm analysis
The gene expression stability over the different samples
was analysed using the geNorm software [9]. The ranking
of the 6 candidate reference genes according to their M
value was not equivalent between the normal skin sam-
ples, the equine sarcoid samples and the combination of
both kinds of samples. For normal skin ACTB, TUBA1 and
UBB  were the 3 most stable genes (Figure 1A(a)). In
equine sarcoids on the other hand, ACTB, B2M and UBB
proved to be the most stable genes with TUBA1 being the
least stable gene (Figure 1B(a)). When both sets of sam-
ples were analysed together, the results showed that the
combination of 3 genes (ACTB, UBB and B2M) is suffi-BMC Biotechnology 2006, 6:24 http://www.biomedcentral.com/1472-6750/6/24
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Gene expression stability of the 6 candidate reference genes analysed by the geNorm program [9] Figure 1
Gene expression stability of the 6 candidate reference genes analysed by the geNorm program [9]. (a) Average 
expression stability values (M) of the control genes, plotted from least stable (left) to most stable (right). (b) Pairwise variation 
analysis between the normalisation factors NFn and NFn+1, to determine the optimal number of control genes for normalisa-
tion. The higher V3/4 value is due to the inclusion of a relative unstable gene and is in accordance with the average expression 
stability M. A – Normal skin. B – Equine sarcoids. C – Combination of normal skin and equine sarcoids.
Figure 1A(a)                Figure 1A(b) 
HPRT1 RPL32 B2M UBB ACTB/TUBA1
<- Least stable genes                        Most stable genes ->
0,20
0,40
0,60
0,80
1,00
1,20
A
v
e
r
a
g
e
 
e
x
p
r
e
s
s
i
o
n
 
s
t
a
b
i
l
i
t
y
 
M
   
V2/3 V3/4 V4/5 V5/6
0,00
0,05
0,10
0,15
0,20
0,25
0,30
P
a
i
r
w
i
s
e
 
v
a
r
i
a
t
i
o
n
 
V
0,144302
0,251597
0,263918
0,234775
Figure 1B(a)                Figure 1B(b) 
TUBA1 HPRT1 RPL32 UBB ACTB/B2M
<- Least stable genes                                   Most stable genes ->
0,80
1,00
1,20
1,40
1,60
1,80
2,00
2,20
A
v
e
r
a
g
e
 
e
x
p
r
e
s
s
i
o
n
 
s
t
a
b
i
l
i
t
y
 
M
   
V2/3 V3/4 V4/5 V5/6
0,00
0,10
0,20
0,30
0,40
0,50
P
a
i
r
w
i
s
e
 
v
a
r
i
a
t
i
o
n
 
V
0,283152
0,344068
0,462437
0,436581
Figure 1C(a)                Figure 1C(b) 
HPRT1 TUBA1 RPL32 B2M ACTB/UBB
<- Least stable genes                              Most stable genes ->
0,80
1,00
1,20
1,40
1,60
1,80
2,00
A
v
e
r
a
g
e
 
e
x
p
r
e
s
s
i
o
n
 
s
t
a
b
i
l
i
t
y
 
M
   
V2/3 V3/4 V4/5 V5/6
0,00
0,10
0,20
0,30
0,40
P
a
i
r
w
i
s
e
 
v
a
r
i
a
t
i
o
n
 
V 0,318519
0,334069
0,387525
0,371717BMC Biotechnology 2006, 6:24 http://www.biomedcentral.com/1472-6750/6/24
Page 4 of 7
(page number not for citation purposes)
cient for adequate normalisation (Figure 1C(a)). The
results are listed in Table 1. In another study [16], where
ACTB, B2M, GAPDH and TBP were compared as reference
genes, ACTB and B2M were found to be the best endog-
enous control genes for real-time qPCR of lamella in the
hoof of horses.
When calculating a normalisation factor (NF), a careful
choice of the number of reference genes should be made.
The more genes included, the more accurate the NF is.
However, including too many genes may increase the risk
of using unsuitable genes, and is also impractical. On the
other hand, if the cut off is made too stringent, stably
expressed reference genes may be excluded and accuracy
might drop. In order to determine how many reference
genes should be included, normalisation factors (NFn),
based on the geometric mean of the expression levels of
the n best reference genes, were calculated by inclusion of
an extra, less stable, reference gene according to Vandes-
ompele et al [9]. Figures 1A(b), 1B(b) and 1C(b) show the
pairwise variation Vn/Vn+1 between 2 sequential normali-
sation factors NFn and NFn+1 for normal skin, equine sar-
coids and the combination of both kinds of samples. In
all 3 cases, the inclusion of a 4th gene had no significant
contribution (low V3/4 value) to the NF. The 3 member
sets as described above are a good choice for the calcula-
tion of the NF.
Implementation of results in clinical research
For the reasons discussed above, we have confidence that
our gene expression results are accurate and reliable. The
described set of reference genes can be used in gene
expression studies both in normal skin, equine sarcoids
and the combination of both. One of the points of interest
in veterinary medicine is the expression level of BPV in
different kinds of equine sarcoids. With the normalisation
technique described in this study, reliable results can be
obtained. Another research topic in this domain is the
study of BPV expression in normal skin, showing latent
infection with BPV. Also, the expression level of specific
horse genes with a putative role in tumourigenesis, can be
investigated.
Conclusion
In conclusion, a method for genomic DNA-free RNA
extraction from normal equine skin and equine sarcoids
was optimised and a reference gene assay for reliable nor-
malisation of real-time qPCR data, obtained from normal
skin, equine sarcoids and the combination of both, was
designed. The profiling of the gene expression pattern of 6
putative reference genes showed that 3 reference genes
should be used. ACTB, TUBA1 and UBB can be used in
normal skin, while ACTB, B2M and  UBB  are the best
choice in equine sarcoids. If normal skin and equine sar-
coids have to be compared, the same member set as pro-
posed for equine sarcoids can be used.
Methods
Sample collection
Eight equine sarcoid samples were obtained from surgi-
cally treated horses. A whole range of tumours were sam-
pled (one occult type, one verrucous type, one nodular
type and five fibroblastic types). Three sarcoids were
located on the medial part of the thigh, two in the axilla
and two on the ventral side of the abdomen. Care was
taken to obtain only tumoural tissue, without underlying
normal stroma. Normal skin samples were obtained from
healthy horses undergoing elective surgery or euthanasia
(umbilical hernia, castration, osteochondrosis dissecans,
dorsal displacement of the soft palatinum). Six of the
samples were collected from the ventral abdomen, one
from the throat region and one from the shoulder. All
samples were freshly collected and stored immediately in
RNAlater (Ambion). After overnight incubation at +4°C,
the samples were frozen at -18°C until RNA extraction.
RNA extraction and cDNA synthesis
Total RNA was isolated from the samples using TRIR
(ABgene) according to the manufacturer's instructions.
Subsequently, approximately 4 µg of the total RNA solu-
tion, measured with the BioPhotometer (Eppendorf),
were treated with 3 units DNase I (Ambion) to remove
genomic DNA. This was followed by a spin-column puri-
fication (Microcon YM-10, Millipore). A minus RT control
with primers for GAPDH was performed to check for suc-
cessful removal of all the contaminating DNA. These
primers were designed by the Primer 3 software [25] using
publicly available sequences from the Nucleotide
Sequence Database from the National Center for Biotech-
nology Information (NCBI) [26]. The initial denaturation
was performed at 94°C for 10 minutes. Thirty-five cycles
of amplification were performed. Each cycle involved a
denaturation step of 30 seconds at 94°C, followed by 30
seconds primer annealing at 61°C and 60 seconds primer
extension at 72°C. After the last cycle, the PCR-mix was
Table 1: Ranking of the reference genes. The reference genes are 
ranked in order of their expression stability in normal equine 
skin, in equine sarcoids and in the combination of both kinds of 
samples, decreasing from top to bottom. The reference genes 
chosen to calculate the normalisation factor, used for comparing 
equine sarcoids and normal skin, are printed in bold.
Normal skin Equine sarcoid Combination
TUBA1 B2M UBB
ACTB ACTB ACTB
UBB UBB B2M
B2M RPL32 RPL32
RPL32 HPRT1 TUBA1
HPRT1 TUBA1 HPRT1BMC Biotechnology 2006, 6:24 http://www.biomedcentral.com/1472-6750/6/24
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heated during 10 minutes at 72°C to become extension of
the partially elongated primers.
First strand cDNA synthesis was carried out on approxi-
mately 2.6 µg of the total RNA solution with Superscript™
II Reverse Transcriptase (Invitrogen), an engineered ver-
sion of M-MLV RT, and a combination of random primers
(Invitrogen) and oligo(dT)20 primers (Invitrogen) in a
total volume of 20 µl, following the manufacturer's
instructions. After this step, a PCR was performed with
primers for GAPDH to check for the presence of cDNA.
The reaction conditions used in this PCR were identical to
the PCR described for the minus RT control.
Reference gene selection and primer design
Six reference genes (ACTB, B2M, HPRT1, UBB, TUBA1
and RPL32) belonging to different functional classes were
selected to reduce the chance that these genes might be co-
regulated (Table 2).
The primers, based on horse RNA and DNA sequences
found in the NCBI database [26], were designed by the
Primer 3 software [25]. The specificity of the primers was
tested using a BLAST analysis against the genomic NCBI
database. The complete nucleotide sequences of the genes
of interest were characterised using Mfold [27] to take into
account possible secondary structures at the primer bind-
ing sites which might influence the PCR efficiency. The
PCR products were cloned (pCR 2.1 vector, Invitrogen)
and sequenced for verification (Thermo Sequenase Primer
Cycle Sequencing Kit, Amersham Bioscience) with an ALF
Express sequencer (Amersham Bioscience). Technical
information about the primers and amplicons are listed in
Table 3.
Real-time quantitative PCR
Eight normal skin samples and eight equine sarcoid sam-
ples were used for quantification of reference genes.
PCR reactions were performed in a 15 µl reaction volume
on the iCycler iQ Real-Time PCR Detection System (Bio-
Rad) using the Platinum® SYBR® Green qPCR SuperMix
UDG (Invitrogen) supplemented with 0.02 µM fluores-
cein and 20 ng of cDNA. Primer concentration varied
according to the primers used. A blank was incorporated
in each assay.
Table 3: Information on the primers used in this study
Gene Genbank accession number Primer sequence Ta (°C) Product size (bp) Primer concentration
ACTB AF035774 CCAGCACGATGAAGATCAAG
GTGGACAATGAGGCCAGAAT
59 88 0.5 µl
10 µM
B2M X69083 GTTCCATCCGCCTGGAGATT
GGGGGTCTTTGAGAGTAGAGTG
60 182 0.25 µl
10 µM
HPRT1 AY372182 GGCAAAACAATGCAAACCTT
CAAGGGCATATCCTACGACAA
60 163 0.5 µl
10 µM
UBB AF506969 GCAAGACCATCACCCTGGA
CTAACAGCCACCCCTGAGAC
61 206 0.5 µl
10 µM
TUBA1 AW260995 GCCCTACAACTCCATCCTGA
ATGGCTTCATTGTCCACCA
60 78 0.5 µl
10 µM
RPL32 CX594263 AGCCATCTACTCGGCGTCA
TCCAATGCCTCTGGGTTTC
61 149 0.25 µl
10 µM
GAPDH AF157626 GATGCCCCAATGTTTGTGA
AAGCAGGGATGATGTTCTGG
61 250 0.5 µl
10 µM
Table 2: Name and function of genes mentioned in the text
Symbol* Gene name* Function
ACTB actin, beta Cytoskeletal structural protein
B2M beta-2-microglobulin Beta-chain of major histocompatibility complex class I molecules
HPRT1 hypoxanthine phosphoribosyltransferase 1 Purine synthesis in salvage pathway
UBB ubiquitin B Protein degradation
TUBA1 tubulin, alpha 1 (testis specific) Structural protein
RPL32 ribosomal protein L32 Member of the 80 different ribosome proteins
GAPDH glyceraldehyde-3-phosphate dehydrogenase Glycolytic enzyme
TBP TATA box binding protein General RNA polymerase II transcription factor
* Nomenclature according to Genew [28]BMC Biotechnology 2006, 6:24 http://www.biomedcentral.com/1472-6750/6/24
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First, an UDG-treatment was done at 50°C to prevent
cross contamination. The initial denaturation was per-
formed at 95°C for 2 minutes to activate the Taq DNA
polymerase, followed by 40 cycles of denaturation at
95°C for 20 seconds and a combined primer annealing/
extension at the specific annealing temperature (Table 3)
for 40 seconds during which fluorescence was measured.
A melt curve was generated to confirm a single gene-spe-
cific peak and to detect primer dimer formation by heat-
ing the samples from 70 to 95°C in 0.5°C increments
with a dwell time at each temperature of 10 seconds while
continuously monitoring the fluorescence.
PCR efficiencies were calculated using a relative standard
curve derived from a pooled cDNA mixture (a ten-fold
dilution series with four measuring points). The pooled
cDNA was obtained from normal equine skin and equine
sarcoids, using the same RNA isolation and cDNA synthe-
sis protocols as described above.
Each reaction was run in duplicate, whereby a no-tem-
plate control was included.
During optimisation of the protocol, the PCR products
were loaded on a 3% agarose gel after each run to confirm
specific gene amplification and the absence of primer
dimer formation.
Determination of reference gene expression stability
To determine the stability of the selected reference genes,
the geNorm Visual Basic application for Microsoft Excel
was used as described by Vandesompele et al [9]. This
approach relies on the principle that the expression ratio
of two perfect reference genes should be identical in all
samples, independent of the experimental condition or
cell type.
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